Government to harness NHS patient data for research use
August 2, 2012Sales and Marketing NHS, R&D, UK, david cameron, innovation, real world data
The UK government will change the NHS Constitution in order to allow patients’ data to be used for research purposes. …
New UK drug pricing system will ‘stifle innovation’
August 2, 2012Sales and Marketing ABPI, PPRS, UK government, VBP
The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …
Daiichi Sankyo: breaking down barriers with social media
August 1, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media
Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …
Olympics to kick-start research ventures
August 1, 2012Research and Development, Sales and Marketing GSK, London 2012, Olympics, research
London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …
MRN posts 533% growth in first five years
August 1, 2012Research and Development clinical trials, growth, results
From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …
Lucid Communication joins forces with Luther Pendragon
August 1, 2012Medical Communications Lucid communications, Luther Pendragon
Communciations agency Luther Pendragon has purchased PR firm Lucid Communication to help expand its US client base. The deal will …
Pfizer’s RA pill impresses in Phase III
August 1, 2012Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA
Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …
Just:: Health PR promotes Laura Chambers to its senior team
July 31, 2012Medical Communications Just:: Health PR, Laura Chambers, just health pr
Just:: Health PR has promoted Laura Chambers to the position of director. Chambers will join fellow directors Tamsin Tierney and …
Lipitor loss continues to hit Pfizer sales
July 31, 2012Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2
Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …
Dendreon slashes staff and closes facility
July 31, 2012Manufacturing and Production, Sales and Marketing Dendreon, M&P, Provenge, prostate cancer
Cancer vaccine specialist Dendreon has said it will slash 600 jobs and close one of its three manufacturing facilities in …
Ariad files new blood cancer drug with the FDA
July 31, 2012Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer
Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …
AstraZeneca launches virtual research laboratory
July 31, 2012Medical Communications Assay Depot, AstraZeneca, R&D, virtual
AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …
Soren Tulstrup to lead Shire’s genetics franchise
July 31, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …
Bayer raises guidance after strong sales
July 31, 2012Sales and Marketing Bayer, Nexavar, Q2, Xarelto, Yasmin
The Bayer Group has raised its full-year guidance for 2012 following positive results in the second quarter. This is despite …
Fitch to pharma: don’t expect 2012 to be a bumper year
July 31, 2012Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings
The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …
Leading producer of auto injectors SHL hires over 600 new employees
July 31, 2012Manufacturing and Production auto injector, autoinjector, pen injector, shl group
In response to increased customer orders and the signing of long-term contracts, SHL has hired more than 600 new employees …
Merck sees growth in second quarter
July 30, 2012Sales and Marketing Cozaar, Merck, Q2, Singulair
Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …
Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops
July 30, 2012Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss
A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
Bayer guilty of multiple Code breaches
July 30, 2012Medical Communications, Sales and Marketing ABPI Code, Bayer, Xarelto, breach, clause
Bayer Healthcare has admitted to 12 breaches of the ABPI Code after one of its staff developed and distributed drug …
Novartis’ David Meek moves to Endocyte
July 30, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment
David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
